Biotage and MIP Technologies have announced that the owners of the two companies have reached an agreement that will see Biotage will acquire all outstanding shares in MIP Technologies and assume ownership of the company.
Biotage and MIP Technologies have announced that the owners of the two companies have reached an agreement that will see Biotage acquire all outstanding shares in MIP Technologies and assume ownership of the company.
“This is an excellent strategic fit regarding Biotage’s expansion and diversification into markets outside of pharma and it will certainly fuel our efforts within sample preparation. One of our ambitions going forward is to further develop our sample preparation business and to drive our consumables sales to get a more even balance between the sale of instruments and consumables,” says Torben Jörgensen, Biotage’s president and CEO in a statement.
MIP Technologies is located in Lund, Sweden and develops solutions for the separations field using proprietary molecularly imprinted polymer (MIP) technology and other novel polymer chemistries.
According to the company, its customers include several multi-national blue chip customers in the food and beverage industries. The company also develops front line analytical products for food, environmental, veterinary and pharmaceutical laboratories.
For more information visit www.biotage.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.